Abstract
Introduction
The specificity of the T cell-dependent adaptive immune interactions may be particularly significant in the context of autoimmune disease, when T cells which respond to a foreign response is conferred by the α and β chains of the TCR, which interact with peptides in the context of class I or II determinant may also cross-react with self-antigen. The importance of such cross-reactive interactions is highlighted by MHC molecules (1). Despite its functional specificity, it is apparent that the TCR can cross-react with different peptides studies performed using analogs of autoantigens which may both prevent (16, 17) or promote autoimmune disease (18, 19) presented in the context of the appropriate restriction element (2,3). In comparison to the cognate ligand, the relative in model systems. In an animal model of multiple sclerosis, experimental response to these different cross-reactive ligands can vary greatly. Some ligands activate the responding T cell as well autoimmune encephalomyelitis, which is induced with a peptide derived from myelin proteolipid protein (PLP) 139-as the cognate ligand, others can hyperstimulate (4-6), hypostimulate, antagonize or anergize T cells (7) (8) (9) (10) (11) . These 151 (referred to here as W144) (20) , CD4 ϩ , T h 1-type T cells are sufficient to induce disease. On the other hand, different outcomes are probably dictated by the strength and length of binding of the peptide-MHC complex to the TCR immunization with an analog of this peptide, Q144 (a tryptophan to glutamine substitution at position 144), and/or by the level of TCR occupancy, although the actual molecular mechanisms responsible for these various outinduces non-pathogenic cross-reactive T cells which respond to W144 by producing T h 2/T h 0 cytokines (16) . Therefore comes have not been clearly defined (12) (13) (14) (15) . Cross-reactive PLP 139-151-reactive T cells, derived following exposure to W144 is 0.6 (A144), 0.8 (L144), 0.6 (Q144), 0.8 (S144) and 1.3 (Neuraminidase 101-120). different cross-reactive immunogens (W144 versus Q144), have fundamentally different effects on the outcome of an Generation of T cells clones autoimmune disease process. One of the important properties Mice were injected s.c. at five sites with 100 µg of Q144 of these protective cells is believed to be their T h 2/T h 0 peptide antigen emulsified in complete Freund's adjuvant phenotype and we therefore wanted to study the cytokine (Difco, Detroit, MI) containing a total of 250 µg Mycobacterium responses of such cross-reactive cells in more detail. Differentuberculosis H37 RA. On day 10 lymph nodes were removed tiated T cell clones are known to have quite stable phenotypes and lymph node cells (LNC) prepared from them. LNC when they are maintained in culture by re-stimulation with the (5ϫ10 6 /well) were cultured in 24-well round-bottom plates immunizing ligand (21). However, the characteristics of T cell (Falcon; Becton Dickinson, Lincoln Park, NJ) for 5 days, in clones maintained on cross-reactive ligands are less well the presence of cross-reactive antigen (W144; 20 µg/ml). T explored. We wondered whether expanding T cells with cell blasts were purified over a Ficoll-Hypaque gradient, and different cross-reactive ligands might affect activation fed with culture medium containing 0.6% T cell growth factor threshold and effector functions of T cells leading to adaptation (T-Stim; Collaborative Biomedical Research, Bedford, MA) of the immune response. and 0.06% recombinant IL-2. Cells were fed every 2-3 days Adaptation could occur by at least two non-exclusive and re-stimulated every 10-18 days with antigen (20 µg/ml) mechanisms. Heterogeneity in the responding population plus irradiated syngeneic spleen cells (5ϫ10 6 cells/ml) as a might allow the differential selection and expansion of a minor source of antigen-presenting cells (APC). T cells were cloned component of that population. Alternatively, cells could show at limiting dilution in round-bottom 96-well tissue culture changes in their activation thresholds as a result of tuning plates after two and three rounds of stimulation. Clones were signaling or surface molecules. The theoretical implications expanded to provide cells for in vitro assays. of such a model have been discussed in the context of the To expand clones on different ligands, equal numbers of tunable activation thresholds model of cell activation both for established QW clones were activated with identical numbers peripheral lymphocytes (22) and also thymocytes (23) , and of spleen cells and equal concentrations of either Q144 or evidence for a role for tuning of thymocytes has been W144 peptide. Activation of these two lines was always described recently (24) , but in the periphery such models carried out with identical numbers of APC, identical amounts of have not been substantiated by experimental data. To investiantigen and at the same time. Proliferation assays were gate some of these possibilities we generated cross-reactive carried out using the same cell numbers and ELISAs were T cells by immunizing SJL (H-2 s ) mice with Q144 peptide, performed with all samples from the same clone, whether but expanding and maintaining the cells with the crossgrown on Q144 or W144, measured on the same plate. reactive peptide W144. We show here that the responding T In vitro proliferation assays and cytokine assays cell clones can be activated by both W144 and Q144, but
Rested T cell clones (1-5ϫ10 4 cells/well) were activated with that Q144 hyperstimulates these T cells, inducing heteroclitic irradiated (3000 rad) syngeneic splenic APC (5ϫ10 5 To generate cross-reactive T cells and investigate the impact of cross-reactive ligands on T cell effector functions (proliferarelative binding of these peptides to I-A s compared with tion and cytokine production), we immunized SJL mice with ligand. However, in comparison with the superagonists described previously, where the superagonist ligands were Q144 peptide. The lymph node T cells were activated and expanded in culture by the cross-reactive ligand W144 which identified by screening analogs of the activating peptide, this series of cross-reactive clones begins to define the basis of generally acts as a suboptimal ligand for the Q144-specific T cell repertoire. The T cells were maintained by activation heteroclicity and hierarchical relationships among various cross-reactive T cell ligands. Therefore expansion of Q144-with W144 and cloned at limiting dilution after two to three rounds of re-stimulation in vitro. Therefore, except for the specific T cells with the suboptimal ligand W144 in vitro results in the generation of T cells for which W144 acts as an initial in vivo immunization with Q144, the clones were always maintained by re-stimulation with W144. They have been optimal ligand and Q144 acts as a 'superagonist ligand'. These results show that expansion by a cross-reactive ligand successfully maintained in culture for Ͼ1 year using this regimen, and are described as QW clones. When the opposite affects the subsequent T cell response to the immunizing antigen. Immunization with Q144 and expansion with Q144 strategy, immunization with W144 and expansion with Q144 was tried, we were unable to clone T cells for functional induces T cells that show a maximal proliferative response at 10-20 µM antigen and produce T h 2/T h 0 cytokines upon analysis.
The clones were all CD4 ϩ and drawn from a diverse activation in vitro (16) . On the other hand, expansion of Q144-specific T cells by a suboptimal cross-reactive ligand, W144, population of precursor T cells as judged by their V β usage (data not shown). All the clones responded to Q144 and results in a cross-reactive population of T cells with a lower threshold (2-4 log) of T cell activation in response to Q144. W144, which suggests that W144 is expanding T cells induced by Q144, rather than by primary in vitro immunizaExpansion with hyperstimulatory ligand alters the activation tion or by expansion of a high-frequency W144-responsive, threshold and the effector phenotype memory T cell population. We examined the proliferative response of the clones over a range of antigen (W144 and
We next investigated the effect of expanding QW T cell clones in vitro with the hyperstimulatory ligand Q144 com-Q144) concentrations. For all but one T cell clone (14 out of 15), Q144 induced a stronger (heteroclitic) proliferative pared with the same cells activated with W144. We considered several possibilities. First, that clones might response when compared to W144 and of these cells we could detect additional T h 1 cytokines from eight out of 14 be hyperstimulated by activation with Q144 and not expand because of activation induced cell death. Second, that cells. The difference in the proliferative responses between W144 and Q144 varied from clone to clone but the lower there may be no detectable difference between clones grown on either ligand in terms of activation thresholds and responses to W144 did not impair the ability of the cells to grow successfully in culture with this ligand. The proliferative cytokine production, since the phenotype of the T cell has been fixed. Third, that the clones might grow on either ligand response of four representative cross-reactive clones to W144 or Q144 ligands is shown in Fig. 1 .
Phenotype of cross-reactive T cell clones
We analyzed the phenotype of the clones based on the pattern of cytokines they secreted following activation with W144 and with Q144. All 15 clones produced T h 2 cytokines (IL-4 and/or IL-10); of these clones, five out of 15 clones also produced low levels of T h 1 cytokines (e.g. IFN-γ) upon activation with W144 peptide. Since W144 is a suboptimal ligand for these Q144-induced T cell clones, this suggests that in this system suboptimal ligands favor T h 2 cytokine production. When we activated the same clones with Q144 we noted that in many cases, in addition to T h 2 cytokines, we could also detect T h 1 cytokines (IFN-γ, tumor necrosis factor-α or IL-2); in many cases we did not detect these cytokines when the clones were activated with W144 even at high antigen concentrations. We did not find clones in which the induction of T h 1 cytokines by Q144 (or other hyperstimulating ligands) was associated with reduction in their T h 2 cytokine production, although some clones showed a lower proliferation in response to the hyperstimulating ligand, probably due to high dose suppression. Data on the cytokine secretion of eight clones is shown in Table 1 .
This pattern of response is analogous to responses to cytokines is not detected on activation with the cognate T cell clones were activated at 25-100 µg/ml of antigen and cytokines measured on day 2. The results are the average of four to six experiments for each clone. Some clones secrete T h 1 cytokines when activated with Q144 but not W144 (underlined).
but their phenotype would change (adaptation). To determine completely from producing IL-4, IL-10, IFN-γ and IL-2 to a T h 2 clone producing IL-4 and IL-10 when the clone was the effect of expanding Q144/W144 cross-reactive clones with Q144 or W144 directly, we took equal numbers of cloned expanded in the presence of Q144 (Fig. 3) . This is consistent with a situation in which clones grown on either ligand can T cells and expanded them under identical tissue culture conditions by re-stimulation with either W144 or Q144.
reach the threshold for T h 2 cytokine stimulation, but only clones grown on W144, which are more sensitive, can reach Four T cell clones were split and maintained on Q144 or W144 in parallel. After at least three rounds of re-stimulation the threshold necessary for T h 1 cytokine secretion. To assess the growth of cells following activation with Q144 and W144, we determined their phenotype. Two of the clones (QW.1D4 and QW.6D10) had very similar dose-response curves when we took cells activated with either W144 or Q144 and compared cell counts for 9 days following activation. There were either ligand was used to maintain them in culture (Fig. 2a) . In contrast, two other clones had shifted their dose response no significant differences between the two ligands (data not shown). to Q144 by~2 log (QW.6F2) or 3 log (QW.7G1) (Fig. 2b) . As a result their sensitivity had decreased, since they required Tuning of activation threshold by two independent higher concentrations of Q144 to achieve half maximal mechanisms in response to expansion by hyperstimulating proliferation. To see if this shift in dose response had affected ligand the response to other cross reactive ligands, we compared the activation of QW.6F2 and QW.7G1 by other ligands (Fig. The mechanism by which the T cell clones adapt and change their proliferative response and cytokine phenotype 2c). The dose-response curves with these ligands were also shifted to the right and QW.7G1, which normally responds to upon re-stimulation with different cross-reactive ligands is unknown. Since we could demonstrate adaptation after A144 and L144, had essentially lost the ability to respond to these two ligands. Therefore the effect of growing QW.7G1 two rounds of activation it seemed likely that it was a short term process and rather unlikely that we were observing on Q144 is to both decrease the sensitivity of the T cell clone and at the same time increase its specificity (Fig. 2c) .
the outgrowth of a minor population of cells. To address the possibility that surface molecules might be modulated, we We also analyzed the impact of growing the T cell clones in the presence of Q144 or W144 cross-reactive ligands on stained for the expression of various surface molecules on T cell clones that were expanded with W144 or Q144. We did cytokine production. We found that the pattern of cytokines secreted by clones grown with the different cross-reactive not find any change in the level of expression of TCR, CD4 or CD28 (Fig. 4 ) in three out of the four clones that we ligands was altered depending upon whether the clone was expanded with W144 or Q144. IL-4 and IL-10 were relatively tested. However, for QW.7G1, we identified a significant decrease in the expression of CD4 (Fig. 4) . To follow this insensitive, in that whether they were expanded by Q144 or W144, IL-4 maintained the same response in three out of four process, we stained cells over sequential activations and found that the number of CD4 -cells approximately doubled clones and IL-10 showed differences in response in two or three clones. In contrast, T h 1 cytokines were much more at each activation between the sixth and the eighth, and by the 11th, cells were essentially negative for CD4 expression sensitive and we saw significant changes in IFN-γ or IL-2 production when clones were maintained with the hyper- (Fig. 5 ). Therefore T cell clones can adapt to hyperstimulation by the outgrowth of a CD4 -population or by tuning CD4 stimulating ligand. The phenotype of QW.7G1 was changed Fig. 2 . Some Q144/W144 T cell clones adapt when they are maintained by re-stimulation with Q144. Equal numbers of QW T cell clones which had been cultured with W144 (closed symbols) or Q144 (open symbols) were activated with either Q144 (squares) or W144 (circles). Chronic re-stimulation had no effect on the proliferative response of some of the clones QW.1D4 and QW.6D10 (a); however, with other clones, QW.6F2 and QW.7G1, there was a shift in the dose-response curves to W144 and Q144 (b). The changes in dose response affected all other crossreactive peptides (A144, diamonds; L144, triangles; S144, inverted triangles) and led, in some cases, to the complete loss of response to some ligands (c). The results are representative of three experiments.
expression. If the loss of CD4 expression from the surface of of a minor population of T cells (over time) which cannot be hyperstimulated by the superagonist ligand. the clone QW.7G1 was also responsible for the changes in the cytokine production from this clone, then changes in cytokine production should correlate with the loss of CD4 Discussion from the surface of this T cell. To address this issue we graphed the changes in cytokine production and loss of CD4
In this paper we have described the generation of crossreactive 'QW' T cell clones, from mice immunized with Q144 with the number of activations by Q144 through time. As shown in Fig. 5 , the changes in the T h 1 cytokines were but expanded in vitro with W144. The clones were of a predominantly T h 2 phenotype when re-stimulated with W144. complete after two activations, whereas loss of CD4 in response to hyperstimulation is a much slower process and Activation of many of the QW clones with Q144 resulted in the production of proinflammatory T h 1 cytokines that we did complete loss of CD4 took at least 10 rounds of activation. These data suggest that the changes in cytokine production not detect when the cells were activated with W144. Compared to W144, the proliferative response to Q144 was heteroclitic, are acutely tuned and may be independent of loss of CD4 in these cells. Therefore short-term changes in effector functions and this response is analogous to superagonist ligands which we and others have described previously. The results may be as a result of other mechanisms such as downregulation of other surface receptors or tuning of intracellular presented here for several clones now begin to explain the basis for heteroclicity and superagonism. The heteroclitic signaling pathways. At least two independent processes appear to take place by which the T cells adapt to hyperstimulresponses and hierarchical relationship can clearly be related to the immunization and expansion strategy, in that activation atory ligands, acute tuning of effector function and selection in vitro by a suboptimal cross-reactive ligand expands T cells of high avidity for Q144 and are sensitive enough to be activated by W144. While we cannot assess the contribution which are hyper-responsive to the immunizing antigen, e.g. activation of QW clones with W144 shifts the dose-response of selection to the final make-up of the QW clone population, we have been able to show that these cells can be rendered curve to Q144 to the left. This results in hyper-proliferation and also changes in the cytokine production of the responding less sensitive by repeated activation with the hyperstimulatory ligand. If low-avidity interactions do maintain T cells in a more T cells when they are activated by Q144, compared with W144.
The differences in the cross-reactive phenotype of T cell reactive state, then the most important implication of this finding is that many different autoreactive T cells may arise populations derived from mice immunized with Q144 and expanded either with Q144 or W144 could occur by the by a similar mechanism, i.e. infection by a pathogen followed by 'rescue' of autoreactive cells by virtue of their ability to selection of a more cross-reactive population of cells from amongst all the cells which respond to Q144 or by the expand when they encounter self-antigen. The mechanism by which activation with low-avidity ligands 'rescues' crossadaptation of cells with Q144-specific TCR so that they are We have attempted to address the question of the mechanism of T cell adaptation by activating cells under identical the heteroclitic responses to Q144 then depends on the proposal that cross-reactive ligands are usually sub-optimal conditions, except for the a change in one amino acid of the ligand used to re-stimulate them in vitro. Whereas a single compared with immunizing ligands (12, 13) . In a population of cells which respond to Q144, W144 will most often be a activation of cross-reactive QW clones with Q144 results in hyperactivation and production of T h 1 cytokines, expansion suboptimal ligand and cells will be more sensitive to Q144 than W144. An alternative explanation is that re-stimulation of the same clones with Q144 causes the T cell clones to adapt. This adaptation affected the function of the clone, by W144 causes adaptation/selection of T cells, which shifts the activation threshold, allowing the T cells to be viable when leading to a decrease in the sensitivity of the response to Q144 and a loss of T h 1 cytokine secretion, occurred within expanded by W144 but hyperstimulated when activated by Q144. These possibilities are not mutually exclusive. Because two rounds of stimulation, and was stable for at least a further three rounds of activation. In one clone we also found a downthe T cell response to Q144 and W144 is diverse at the level of the TCR, it is difficult to distinguish between these two regulation of CD4 over time, in a manner which is consistent autoantigen. Because the interaction with the autoantigen W144 is suboptimal, it favors the production of T h 2 cytokines which are often (but not always) non-pathogenic in organ-specific autoimmune disease. Therefore memory cells, which are necessarily cross-reactive with self-antigen, are less pathogenic when stimulated by the autoantigen than by the immunizing peptide. The observation that long-term adaptation is sometimes associated with a down-regulation of CD4, in a manner which is consistent with the outgrowth of a CD4 -population under the selection pressure imposed by activation with hyperstimulating ligand, Q144, is intriguing. Activation thresholds can clearly be modulated by CD4 levels (29,30) and although CD4/CD8 -populations are infrequent in normal mice, they are a striking feature of mrl/lpr mice (31) . These mice have a defect in Fas-mediated apoptosis which leads to a failure of activation-induced cell death (32). We therefore hypothesize that the accumulation of CD4 -cells in these mice represents the down-regulation of CD4 on autoreactive T cells, which would normally be eliminated by Fas-dependent apoptosis.
In summary we have shown how exposure to a crossreactive ligand leads to a change in activation threshold and effector function of a clonal population of T cells. From our data it appears that the activation thresholds and effector functions of T cells are tunable. We find that T cell recognition has two essential and distinct components: TCRs function to define the specificity and hierarchy of ligand recognition, but T cell function is determined by the activation threshold of the cell, which is in turn defined by the T cell's history. The data presented here shows that the response of two T cells, with identical receptors but which have encountered different The data presented here shows that the effector functions of a T cell may be tuned by previous exposure of the cell to cross-reactive ligands. This is consistent with experiments Abbreviations using a TCR transgenic mouse that show that the expression consistent with a model of affinity selection for T cell memory. This type of model, which has been proposed elsewhere (27, 28) predicts that memory cells have TCR which crossReferences react with autoantigens and it is this sub-optimal stimulation predominantly heteroclitic response which we observe to Immunol. 10:835. Q144, this mechanism may also serve to select TCR which 2 Bevan, M. J. 1997. In thymic selection, peptide diversity gives and takes away. Immunity 7:175.
have a high avidity for the immunogen but low avidity for the
